Kellum shows as a "shareholder" and it was founded in
2012..
Kellum was the lead DSMB man in the phase 3 Euphrates trial.
* HE saw every stitch of data including the 194 patients that now form a minimum of 40% of the current phase 3B TIGRIS study.
Looks like he has been an integral part of Spectral for about a decade.
Given he expressed 38 different disclosures in a Setember 2020 video, his decision to come here HAD ZERO surprises ( IMHO ) I would suggest he is WELl aware of "Spectral" and all the various chapters of the continuing saga..